Sort
10,766 grants matching “checkpoint inhibitor”
The Role of Egfl6 in Tumor Immunity
$305,930Sandra Cascio · Magee-Women'S Res Inst And Foundation · R01 · FY2024 · CA
Single Agents with Designed Combination Chemotherapy Potential
$305,782Aleem Gangjee · Duquesne University · R01 · FY2009 · CA
Gadd45beta in JNK Signaling, Apoptosis, and Cancer
$305,381University Of Chicago · R01 · FY2003 · CA
Gadd45beta in JNK Signaling, Apoptosis, and Cancer
$305,381University Of Chicago · R01 · FY2004 · CA
Molecular Targeting of the Survivin Pathway in Cancer
$305,336Yale University · R01 · FY2001 · CA
Clinical specimen tumor-TME acquired resistance
$305,261Trever G Bivona · University Of California, San Francisco · U54 · FY2023 · CA
Project 3: Improving therapeutic approaches for breast cancer brain metastases
$305,118Jean Zhao · Dana-Farber Cancer Inst · P50 · FY2021 · CA
Mrad9 Radioresistance Gene
$305,079Columbia University Health Sciences · R01 · FY2001 · CA
Mechanisms of UV-induced skin carcinogenesis
$304,938Laura A Hansen · Creighton University · R01 · FY2009 · ES
Mechanisms of UV-induced skin carcinogenesis
$304,938Laura A Hansen · Creighton University · R01 · FY2008 · ES
Mitosis, Aneuploidy and Cancer
$304,917Beth A Weaver · University Of Wisconsin-Madison · R01 · FY2012 · CA
Mitosis, Aneuploidy and Cancer
$304,917Beth A Weaver · University Of Wisconsin-Madison · R01 · FY2015 · CA
Mitosis, Aneuploidy and Cancer
$304,917Beth A Weaver · University Of Wisconsin-Madison · R01 · FY2011 · CA
Large-Scale Genetic Analyses of Human Cancer
$304,903Victor E Velculescu · Johns Hopkins University · R01 · FY2022 · CA
Regulation of the Anaphase-Promoting Complex by the Spindle Checkpoint
$304,894Hongtao Yu · Ut Southwestern Medical Center · R01 · FY2008 · GM
Regulation of the Anaphase-Promoting Complex by the Spindle Checkpoint
$304,894Hongtao Yu · Ut Southwestern Medical Center · R01 · FY2009 · GM
Regulation of the Anaphase-Promoting Complex by the Spindle Checkpoint
$304,894Hongtao Yu · Ut Southwestern Medical Center · R01 · FY2007 · GM
Oligomannose antigens as conserved immunological targets of Non-Hodgkin lymphomas
$304,653Denong Wang · Sri International · R21 · FY2022 · CA
Antigen-specific T cells in immunotherapy-associated acute kidney injury
$304,391Naoka Murakami · Washington University · R01 · FY2025 · DK
Role of the Acetyltransferase p300 in Cellular Responses
$304,380Georgetown University · R01 · FY2004 · CA
Role of Fus1-mediated antitumor CD8T-NK crosstalk in Alzheimer's disease pathology
$304,367Anil Shanker · Meharry Medical College · SC1 · FY2019 · CA
Project 2: Targeting Immune Vulnerabilities in Lung Cancer
$304,170John V. Heymach · Ut Southwestern Medical Center · P50 · FY2020 · CA
PTP1b Inhibition Restores the Innate Anti-tumor Response During Chemotherapy
$304,110Eric S Ubil · University Of Alabama At Birmingham · R01 · FY2024 · CA
Project 3: Mechanisms of immunotherapy action
$304,056Marcia Haigis · Harvard Medical School · U54 · FY2019 · CA
Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer
$304,054Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2013 · CA